CN103006809A - Traditional Chinese medicine decoction for treating systemic lupus erythematosus - Google Patents
Traditional Chinese medicine decoction for treating systemic lupus erythematosus Download PDFInfo
- Publication number
- CN103006809A CN103006809A CN201210492344XA CN201210492344A CN103006809A CN 103006809 A CN103006809 A CN 103006809A CN 201210492344X A CN201210492344X A CN 201210492344XA CN 201210492344 A CN201210492344 A CN 201210492344A CN 103006809 A CN103006809 A CN 103006809A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- chinese medicine
- medicine decoction
- lupus erythematosus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to the field of pharmaceutical formulation, and in particular relates to a traditional Chinese medicine decoction for treating systemic lupus erythematosus. The traditional Chinese medicine decoction is characterized in that the bulk drug comprises the following components in parts by weight: 5-11 parts of tuckahoe, 8-14 parts of dodder, 5-11 parts of herba epimedii, 5-11 parts of Atractylis ovata, 8-14 parts of broom cypress fruit, 5-11 parts of codonopsis pilosula, 5-11 parts of Chinese thorowax, 6-12 parts of roasted liquorice, 6-12 parts of radix scutellariae, 6-12 parts of cornel, 5-9 parts of radix paeoniae rubra, 8-14 parts of southernwood, 8-14 parts of Eclipta alba, and 6-12 parts of rhizoma cimicifugae; and the 14 bulk drug ingredients are mixed, then soaked with water and decocted, and dregs are removed to obtain the filtrate. The traditional Chinese medicine decoction for treating systemic lupus erythematosus is low in cost and relatively high in treating effective rate, and has no obvious toxic side effect.
Description
Technical field
The present invention relates to a kind of Chinese patent medicine preparation, specifically a kind of Chinese medicine decoction of systemic lupus erythematosus nephritis.
Background technology
As everyone knows, lupus nephritis is a kind of common and serious complication of systemic lupus erythematosus (sle), mostly betides systemic lupus erythematosus (sle) and rises in after being ill 5 years.Systemic lupus erythematosus (sle) is a kind of autoimmune disease of complexity, involves multisystem, many organs.When systemic lupus erythematosus (sle) damages kidney, be lupus nephritis, such as untimely treatment and control, can finally develop into uremia, cause patient's death.At present, the method for the most general treatment lupus nephritis is exactly that glucocorticoid adds the cell toxicity medicament cyclophosphamide, but because its side effect is more, application clinically has been subject to a lot of restrictions.
Summary of the invention
Purpose of the present invention is exactly to provide a kind of Chinese medicine decoction of systemic lupus erythematosus nephritis in order to overcome above-mentioned existing technical deficiency, and cost is low, do not have obvious toxic-side effects, treated effect is higher.
The technical scheme that the present invention solves the problems of the technologies described above employing is: a kind of Chinese medicine decoction of systemic lupus erythematosus nephritis, it is characterized in that, the weight portion of crude drug is, 5～11 parts in Poria, 8～14 parts of Semen Cuscutae, 5～11 parts of Herba Epimedii, 5～11 parts of the Rhizoma Atractylodis Macrocephalaes, 8～14 parts of the Fructus Kochiae, 5～11 parts of Radix Codonopsis, 5～11 parts of Radix Bupleuri, 6～12 parts of Radix Glycyrrhizae Preparata, 6～12 parts of Radix Scutellariaes, 6～12 parts of Fructus Corni, 5～9 parts of Radix Paeoniae Rubra, 8～14 parts of Herba Artemisiae Annuaes, 8～14 parts of Herba Ecliptaes, 6～12 parts of Rhizoma Cimicifugaes, after mixing, 14 flavor crude drug are soaked in water the filtrate of removing slag to get after decocting.
The weight portion preferable range of each crude drug of the present invention is: 8 parts in Poria, 12 parts of Semen Cuscutae, 8 parts of Herba Epimedii, 8 parts of the Rhizoma Atractylodis Macrocephalaes, 10 parts of the Fructus Kochiae, 8 parts of Radix Codonopsis, 8 parts of Radix Bupleuri, 10 parts of Radix Glycyrrhizae Preparata, 10 parts of Radix Scutellariaes, 10 parts of Fructus Corni, 7 parts of Radix Paeoniae Rubra, 10 parts of Herba Artemisiae Annuaes, 10 parts of Herba Ecliptaes, Rhizoma Cimicifugae 8.
The invention has the beneficial effects as follows that cost is low, do not have obvious toxic-side effects, treated effect is higher.
The specific embodiment
The invention will be further described below in conjunction with embodiment:
Embodiment 1:
Adopt Poria, Semen Cuscutae, Herba Epimedii, the Rhizoma Atractylodis Macrocephalae, the Fructus Kochiae, Radix Codonopsis, Radix Bupleuri, Radix Glycyrrhizae Preparata, Radix Scutellariae, Fructus Corni, Radix Paeoniae Rubra, Herba Artemisiae Annuae, Herba Ecliptae, Rhizoma Cimicifugae is that crude drug is prepared from, the every clothes of its component (weight portion) are 8 parts in Poria, 12 parts of Semen Cuscutae, 8 parts of Herba Epimedii, 8 parts of the Rhizoma Atractylodis Macrocephalaes, 10 parts of the Fructus Kochiae, 8 parts of Radix Codonopsis, 8 parts of Radix Bupleuri, 10 parts of Radix Glycyrrhizae Preparata, 10 parts of Radix Scutellariaes, 10 parts of Fructus Corni, 7 parts of Radix Paeoniae Rubra, 10 parts of Herba Artemisiae Annuaes, 10 parts of Herba Ecliptaes, Rhizoma Cimicifugae 8, getting above-mentioned 14 kinds of crude drug gross weights, 180 grams mixes, soaked 1 hour with clean water, water consumption 1200ml, after intense fire is fried open, use slow fire boiling instead, extracting juice 200ml, two fry in shallow oil and add water 300ml, decocting extracting juice 200ml, two fry in shallow oil mixing, fry in shallow oil again and be concentrated into 300ml, the sterile vacuum packing, preparation gets product.Every day potion divide 2 times oral, each sooner or later (medicine) being taken before meal 150ml.
Poria of the present invention: sweet in the mouth, light, property is flat.The effect promoting diuresis to eliminate damp pathogen, spleen invigorating is calmed the nerves.Cure mainly: be used for the water damp syndrome, such as dysuria, edema is stopped drink, etc.; Semen Cuscutae: invigorating the liver and kidney, beneficial marrow makes eye bright.Control soreness of waist and knee joint, seminal emission is quenched one's thirst; Herba Epimedii: hot, sweet, temperature is returned liver, kidney channel.Has kidney-replenishing, bone and muscle strengthening, the effect of wind-damp dispelling; The Rhizoma Atractylodis Macrocephalae: invigorating the spleen and benefiting QI, the dampness diuretic, hidroschesis, antiabortive.Be used for insufficiency of the spleen lack of appetite, abdominal distention is had loose bowels, phlegm retention vertigo and palpitation, edema, spontaneous perspiration, frequent fetal movement; The Fructus Kochiae: clearing away heat-damp and promoting diuresis, dispelling wind for relieving itching is used for difficulty and pain in micturition, pudendal pruritus leukorrhagia, rubella, eczema, skin pruritus; Radix Codonopsis: invigorating middle warmer, QI invigorating is promoted the production of body fluid.Control weakness of the spleen and stomach, deficiency of both QI and blood, fatigue and lack of strength, lack of appetite, thirsty, chronic diarrhea, proctoptosis.Control the asthenia internal injury, intestinal cold in the stomach, the sliding chronic dysentery of rushing down, asthma excessive thirst; Radix Bupleuri: bitter in the mouth, cold nature.Return liver, gallbladder meridian.Have to evacuate and bring down a fever soothing liver-QI, the function of yang invigorating.Be used for cold, fever, alternate attack of chill and fever, malaria, distending pain in the chest and hypochondrium, menoxenia, uterine prolapse, the diseases such as proctoptosis; Radix Glycyrrhizae Preparata: spleen reinforcing stomach function regulating, Yiqi and vein recovery.Be used for weakness of the spleen and stomach, fatigue and weakness, severe palpitation, irregularly intermittent and regularly intermittent pulse; Radix Scutellariae: heat clearing and damp drying, eliminating fire and detoxication, hemostasis, antiabortive.Be used for hygropyrexia, fever disease in summer vomiting and nausea uncomfortable in chest, damp and hot feeling of fullness, dysentery, jaundice, cough due to lung-heat, high hot excessive thirst; Fructus Corni: meridian distribution of property and flavor: sour, puckery, tepor.Return liver, kidney channel.Function cures mainly: liver and kidney tonifying, essence astringing and desertion stemming.Be used for vertigo and tinnitus, soreness of waist and knee joint, impotence and seminal emission, enuresis frequent micturition, bleeding not during menses, profuse sweating collapse; Radix Paeoniae Rubra: energy promoting blood circulation to restore menstrual flow, cool the blood dissipate blood stasis, heat-clearing and toxic substances removing.Cure mainly the diseases such as amenorrhea due to stagnation of blood, herpes simplex toxic swelling, postnatal blood stasis, heat in blood epistaxis, warm malicious macule; Herba Artemisiae Annuae: clearing away heat to improve acuity of vision, parasite killing.The Zhi Fangre hectic fever due to YIN-deficiency, dysentery, malignant boil, scabies, rubella; Herba Ecliptae: sweet acid, cold.Enter kidney, liver.Stomach, intestine and small intestine.Control haematemesis, hemoptysis, epistaxis, hematuria is had blood in stool, dysentery, knife injury is hemorrhage, early whitening of beard and hair; Rhizoma Cimicifugae: meridian distribution of property and flavor: sweet, hot, be slightly cold.Return spleen, stomach, lung, large intestine channel.Efficacy of drugs: deliver rash, heat-clearing and toxic substances removing, elevate a turnable ladder yang-energy.
But each raw material of the present invention also embodiment of the listed part by weight mixing of according to the form below is realized.Its processing technique is identical with embodiment 1.(unit: weight portion)
Below in conjunction with my institute, namely the clinical preliminary test that carries out of In Shandong Weihai institute of traditional Chinese medicine is done further, is described in detail the present invention:
1, clinical data: clinically select at random 60 routine patients, all patients are SLE nephritis.
2, Therapeutic Method: medicine potion every day of the present invention divide 2 times oral, each sooner or later (medicine) being taken before meal 150ml serve on 90 days.
3, diagnostic criteria: a, Pathological prompt for IIb, III, IV, the V-type of WHO pathological; B, flesh creatinine clearance rate decline 30% in 1 year; C, twenty-four-hour urine protein quantification＞1g.Possess in above-mentioned three any one, should be thought of as lupus nephritis.As lack above-mentioned evidence, should possess 3 in following at least: a, albumin＜3g/dl; B, albuminuria continue ++～++ ++; C, urine examination have liposome, hyaline cast, granular cast or red cell cast; D, persistent hematuria (＞5 erythrocyte/high power fields).Must get rid of other reasons as warding off the nephropathy due to urine disease, hypertension, medicine, the infection etc.
4, curative effect is judged: be divided into healing, produce effects, effective, invalid 4 ranks.Cure: symptom, sign and laboratory procuratorial work full recovery are normal, do not recur in 3 years.Produce effects: symptom, sign disappear, and laboratory procuratorial work indices approaches normal.Or there is 80% index subjet to recover normal; Effectively: symptom, sign are obviously improved, and laboratory procuratorial work index makes moderate progress; Invalid: symptom, sign and laboratory procuratorial work index are unchanged or increase the weight of.
5, therapeutic effect: use the present invention to treat altogether 60 examples, cure 21 examples, produce effects 34 examples, effective 3, invalid 2 examples, total effective rate 97% (comprise healing, produce effects, effectively).
Claims (2)
1. the Chinese medicine decoction of a systemic lupus erythematosus nephritis, it is characterized in that: the weight portion of crude drug is, 5～11 parts in Poria, 8～14 parts of Semen Cuscutae, 5～11 parts of Herba Epimedii, 5～11 parts of the Rhizoma Atractylodis Macrocephalaes, 8～14 parts of the Fructus Kochiae, 5～11 parts of Radix Codonopsis, 5～11 parts of Radix Bupleuri, 6～12 parts of Radix Glycyrrhizae Preparata, 6～12 parts of Radix Scutellariaes, 6～12 parts of Fructus Corni, 5～9 parts of Radix Paeoniae Rubra, 8～14 parts of Herba Artemisiae Annuaes, 8～14 parts of Herba Ecliptaes, 6～12 parts of Rhizoma Cimicifugaes, after mixing, 14 flavor crude drug are soaked in water the filtrate of removing slag to get after decocting.
2. the Chinese medicine decoction of described a kind of systemic lupus erythematosus nephritis according to claim 1, the weight portion that it is characterized in that said crude drug is 8 parts in Poria, 12 parts of Semen Cuscutae, 8 parts of Herba Epimedii, 8 parts of the Rhizoma Atractylodis Macrocephalaes, 10 parts of the Fructus Kochiae, 8 parts of Radix Codonopsis, 8 parts of Radix Bupleuri, 10 parts of Radix Glycyrrhizae Preparata, 10 parts of Radix Scutellariaes, 10 parts of Fructus Corni, 7 parts of Radix Paeoniae Rubra, 10 parts of Herba Artemisiae Annuaes, 10 parts of Herba Ecliptaes, Rhizoma Cimicifugae 8.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201210492344.XA CN103006809B (en) | 2012-11-14 | 2012-11-14 | Traditional Chinese medicine decoction for treating systemic lupus erythematosus |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201210492344.XA CN103006809B (en) | 2012-11-14 | 2012-11-14 | Traditional Chinese medicine decoction for treating systemic lupus erythematosus |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103006809A true CN103006809A (en) | 2013-04-03 |
| CN103006809B CN103006809B (en) | 2014-02-19 |
Family
ID=47956272
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201210492344.XA Active CN103006809B (en) | 2012-11-14 | 2012-11-14 | Traditional Chinese medicine decoction for treating systemic lupus erythematosus |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103006809B (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104491248A (en) * | 2014-12-23 | 2015-04-08 | 张晓利 | Drug for treating primary thrombocythemia and preparation method thereof |
| CN111700940A (en) * | 2020-07-31 | 2020-09-25 | 潍坊医学院 | Traditional Chinese medicine composition for treating maintenance stage lupus nephritis |
-
2012
- 2012-11-14 CN CN201210492344.XA patent/CN103006809B/en active Active
Non-Patent Citations (1)
| Title |
|---|
| 钟文冠: "慢性肾小球疾病的中医药治疗研究", 《中国博士学位论文全文数据库》 * |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104491248A (en) * | 2014-12-23 | 2015-04-08 | 张晓利 | Drug for treating primary thrombocythemia and preparation method thereof |
| CN111700940A (en) * | 2020-07-31 | 2020-09-25 | 潍坊医学院 | Traditional Chinese medicine composition for treating maintenance stage lupus nephritis |
| CN111700940B (en) * | 2020-07-31 | 2021-11-05 | 潍坊医学院附属医院 | Traditional Chinese medicine composition for treating maintenance stage lupus nephritis |
Also Published As
| Publication number | Publication date |
|---|---|
| CN103006809B (en) | 2014-02-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103550517B (en) | A kind of medicine of Hepatoma therapy | |
| CN101912585B (en) | Medicament for treating myoma of uterus and preparation method thereof | |
| CN103751570A (en) | Orally taken traditional Chinese medicine for treating migraine | |
| CN104013825A (en) | Traditional Chinese medicine composition for treating diabetes | |
| CN100360171C (en) | Chinese medicine preparation for treating deficiency of qi and blood and preparing method | |
| CN102895400B (en) | Traditional Chinese medicine decoction for treatment of diabetic constipation of elderly | |
| CN102552793B (en) | Chinese medicinal composition for treating unstable angina pectoris derived from aged coronary heart disease | |
| CN103006881B (en) | Traditional Chinese medicine decoction for treating eczema | |
| CN102357211A (en) | Traditional Chinese medicine composition for curing cancers | |
| CN101637576B (en) | Traditional Chinese medicine for treating nephritis | |
| CN101085251A (en) | Traditional Chinese medicine preparation for treating nephrotic syndrome | |
| CN103006809B (en) | Traditional Chinese medicine decoction for treating systemic lupus erythematosus | |
| CN102908555A (en) | Chinese medicament for treating edema | |
| CN105326993A (en) | Traditional Chinese medicine composition for treating spermatorrhea and premature ejaculation | |
| CN101912502B (en) | Traditional Chinese medicine for treating acute urethrocystitis | |
| CN103751721A (en) | Traditional Chinese medicinal composition for treating bladder cancer | |
| CN102580021B (en) | Turtle cream greenish white soup for primary glomerulonephritis | |
| CN102106997A (en) | Oral Chinese medicine decoction for treating endometriosis | |
| CN105079549A (en) | Traditional Chinese medicine for treating lupus nephritis | |
| CN101116710A (en) | Chinese traditional medicine preparations for treating postpartum dysuria | |
| CN101095760A (en) | Chinese traditional medicine composition for treating diabetes neurogenic bladder | |
| CN104257986A (en) | Traditional Chinese medicine for treating nephritis | |
| CN104398789A (en) | Traditional Chinese medicine decoction for treating iron-deficiency anemia | |
| CN104352709A (en) | Medicine for treating gastric ulcer and preparation method of medicine | |
| CN104257813B (en) | A kind of Chinese medicine composition of QI and blood regulating and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| ASS | Succession or assignment of patent right |
Owner name: NANTONG JIUWUBA TECHNOLOGY BUSINESS INCUBATOR CO., Free format text: FORMER OWNER: HU YANLING Effective date: 20141105 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 264400 WEIHAI, SHANDONG PROVINCE TO: 226300 NANTONG, JIANGSU PROVINCE |
|
| TR01 | Transfer of patent right |
Effective date of registration: 20141105 Address after: 226300 Industrial Park, Jinsha Town, Nantong, Jiangsu, Tongzhou District Patentee after: SUZHOU HENGKANG NEW MATERIAL CO., LTD. Address before: 264400 Wendeng, Shandong, Zhejiang Province, East Hill Road, No. 3, Wendeng Central Hospital, Weihai Patentee before: Hu Yanling |
|
| TR01 | Transfer of patent right | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20170622 Address after: 226300 No. 10 Daqing Road, Jinsha Town, Nantong, Jiangsu, Tongzhou District Patentee after: Jiangsu coastal agricultural science and Technology Development Co Ltd Address before: 226300 Industrial Park, Jinsha Town, Nantong, Jiangsu, Tongzhou District Patentee before: SUZHOU HENGKANG NEW MATERIAL CO., LTD. |